| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
14 companies
Makhzoumi Mohamad serves as a 10% Owner at SVRA and has filed Form 4s across 14 companies. Across recent SEC filings that breaks down to 16 buys and 4 sells. Those positions are worth an estimated $182.4M at current prices.
Historically, Makhzoumi Mohamad's trades have earned a middling insider score of 56/100 across 11 rated trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -19.4%.
The biggest single holding is SVRA (~$73.4M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 333,333 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 207,100 | $11.11 | $2,300,881.00 | +19.0% | -7.8% | - | |
| Feb 9, 2026 | SGP Spyglass Pharma, Inc. | 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +18.4% | -9.2% | - | |
| Sep 16, 2024 | MBX Mbx Biosciences, Inc. | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Apr 22, 2024 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 17,857 | $56.00 | $999,992.00 | +1.7% | -29.2% | -76.1% | |
| Jul 17, 2023 | SVRA Savara Inc | 10% Owner | Buy | 333,333 | $3.00 | $999,999.00 | +1.4% | +11.8% | +58.0% | |
| Dec 21, 2022 | ACLX Arcellx, Inc. | 10% Owner | Sell | 179 | $30.74 | $5,501.96 | -100% | -3.4% | +67.0% | |
| May 3, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 1,952 | $10.06 | $19,640.44 | -100% | -10.5% | -17.0% | |
| Apr 11, 2022 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 3,580,526 | $1.90 | $6,802,999.40 | -136.1% | +31.2% | -32.7% | |
| Jan 31, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 2,082 | $14.22 | $29,597.71 | -100% | -25.9% | -26.4% | |
| Oct 18, 2021 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% |